[go: up one dir, main page]

MX2019007902A - Composiciones para el tratamiento de seres humanos. - Google Patents

Composiciones para el tratamiento de seres humanos.

Info

Publication number
MX2019007902A
MX2019007902A MX2019007902A MX2019007902A MX2019007902A MX 2019007902 A MX2019007902 A MX 2019007902A MX 2019007902 A MX2019007902 A MX 2019007902A MX 2019007902 A MX2019007902 A MX 2019007902A MX 2019007902 A MX2019007902 A MX 2019007902A
Authority
MX
Mexico
Prior art keywords
treatment
microbial lysozyme
inflammatory bowel
bowel disease
bowel syndrome
Prior art date
Application number
MX2019007902A
Other languages
English (en)
Inventor
Thorup COHN Marianne
Ny KRISTENSEN Nanna
Kjaerulff Soeren
Original Assignee
Novozymes As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novozymes As filed Critical Novozymes As
Publication of MX2019007902A publication Critical patent/MX2019007902A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/06—Enzymes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/195—Proteins from microorganisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2462—Lysozyme (3.2.1.17)
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01017—Lysozyme (3.2.1.17)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • General Engineering & Computer Science (AREA)
  • Child & Adolescent Psychology (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

La presente invención se refiere a la lisozima microbiana, composiciones que la comprenden y usos de la misma.
MX2019007902A 2017-01-04 2018-01-04 Composiciones para el tratamiento de seres humanos. MX2019007902A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP17150258 2017-01-04
EP17155110 2017-02-08
EP17209209 2017-12-21
PCT/EP2018/050189 WO2018127532A1 (en) 2017-01-04 2018-01-04 Microbial lysozyme for use in the treatment of irritable bowel syndrome or inflammatory bowel disease

Publications (1)

Publication Number Publication Date
MX2019007902A true MX2019007902A (es) 2019-09-09

Family

ID=61022310

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019007902A MX2019007902A (es) 2017-01-04 2018-01-04 Composiciones para el tratamiento de seres humanos.

Country Status (13)

Country Link
US (3) US11179447B2 (es)
EP (2) EP3565582B1 (es)
JP (1) JP7319920B2 (es)
KR (1) KR102673484B1 (es)
CN (1) CN110267676A (es)
AU (1) AU2018205999B2 (es)
BR (1) BR112019013574A2 (es)
CA (1) CA3048773A1 (es)
ES (1) ES2915100T3 (es)
IL (1) IL267767A (es)
MX (1) MX2019007902A (es)
MY (1) MY191930A (es)
WO (1) WO2018127532A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11896033B2 (en) 2016-12-21 2024-02-13 Novozymes A/S Polypeptides having lysozyme activity, polynucleotides encoding same and uses and compositions thereof
AU2017380488B2 (en) 2016-12-21 2023-09-14 Novozymes A/S Polypeptides having lysozyme activity, polynucleotides encoding same and uses and compositions thereof
CN112439055A (zh) * 2019-08-29 2021-03-05 湘北威尔曼制药股份有限公司 用于预防或治疗尿酸性疾病的组合物
CN112704730A (zh) * 2019-10-25 2021-04-27 湘北威尔曼制药股份有限公司 预防或治疗肠易激综合征的药物组合
US20240034960A1 (en) 2020-08-27 2024-02-01 Danisco Us Inc Enzymes and enzyme compositions for cleaning

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK122686D0 (da) 1986-03-17 1986-03-17 Novo Industri As Fremstilling af proteiner
WO2000021381A1 (en) 1998-10-15 2000-04-20 Dsm N.V. Antimicrobial enzymes in animal feed
WO2002040694A2 (en) 2000-11-17 2002-05-23 Novozymes A/S Heterologous expression of taxanes
CA2404356A1 (en) 2002-09-18 2004-03-18 Canadian Inovatech Inc. Gram-positive antibacterial composition and method for use
GB2379166A (en) 2002-10-22 2003-03-05 Dsm Nv Animal feed
EP1682655B1 (en) 2003-10-30 2009-09-02 Novozymes A/S Carbohydrate-binding modules
JP2009513572A (ja) * 2005-09-28 2009-04-02 ベントリア バイオサイエンス 腸管障害及び／又は下痢用の経口組成物
JP2009263307A (ja) 2008-04-28 2009-11-12 Taiyo Kagaku Co Ltd 炎症性腸疾患の予防・治療剤
EP2609195A4 (en) 2010-08-23 2014-03-05 Codexis Inc RECOMBINANT LIGNOCELLULOSE REMOVAL ENZYME FOR THE PRODUCTION OF SOLUBLE SUGAR FROM A CELLULOSE BIOMASS
WO2012027374A2 (en) 2010-08-23 2012-03-01 Dyadic International (Usa) Inc. Novel fungal carbohydrate hydrolases
EP2782592B1 (en) * 2011-11-25 2017-03-15 Novozymes A/S Polypeptides having lysozyme activity and polynucleotides encoding same
US20150337279A1 (en) 2012-11-20 2015-11-26 Codexis, Inc. Recombinant fungal polypeptides
US10568344B2 (en) * 2015-07-02 2020-02-25 Novozymes A/S Methods of improving animal performance
EP3316699B1 (en) * 2015-07-02 2021-09-08 Novozymes A/S Animal feed compositions comprising gh25 lysozyme and 4-phytase and uses thereof

Also Published As

Publication number Publication date
US11179447B2 (en) 2021-11-23
EP3565582A1 (en) 2019-11-13
US20240325508A1 (en) 2024-10-03
AU2018205999B2 (en) 2024-12-19
CN110267676A (zh) 2019-09-20
ES2915100T3 (es) 2022-06-20
US12053509B2 (en) 2024-08-06
US20190351032A1 (en) 2019-11-21
KR102673484B1 (ko) 2024-06-10
AU2018205999A1 (en) 2019-06-27
KR20190103234A (ko) 2019-09-04
IL267767A (en) 2019-09-26
MY191930A (en) 2022-07-19
US20220118061A1 (en) 2022-04-21
JP7319920B2 (ja) 2023-08-02
EP4052722A1 (en) 2022-09-07
WO2018127532A1 (en) 2018-07-12
JP2020513771A (ja) 2020-05-21
BR112019013574A2 (pt) 2020-06-23
EP3565582B1 (en) 2022-03-09
CA3048773A1 (en) 2018-07-12

Similar Documents

Publication Publication Date Title
ZA201905488B (en) Tigit- and light-based chimeric proteins
CY1124013T1 (el) Συνθεσεις που περιλαμβανουν βακτηριακα στελεχη
CY1125136T1 (el) Συνθεσεις που περιλαμβανουν βακτηριακα στελεχη
CY1122184T1 (el) Συνθεσεις περιλαμβανουσες βακτηριακα στελεχη
EA201891199A1 (ru) Композиции, содержащие бактериальные штаммы
EA201890047A1 (ru) Композиции, содержащие бактериальные штаммы
EA201890048A1 (ru) Композиции, содержащие бактериальные штаммы
EA201891202A1 (ru) Композиции, содержащие бактериальные штаммы
EA201891201A1 (ru) Композиции, содержащие бактериальные штаммы
MX2017001971A (es) Composiciones antimetanogenicas y sus usos.
WO2015003816A3 (en) Cystobactamides
MX2019007902A (es) Composiciones para el tratamiento de seres humanos.
PH12018501279A1 (en) Compositions comprising 15-hepe and methods of using the same
PH12019502915A1 (en) Immunogenic compositions
MX2020001632A (es) Composiciones que comprenden cepas bacterianas.
EA201991651A1 (ru) Микробный лизоцим для применения в лечении синдрома раздраженного кишечника или воспалительного заболевания кишечника
MA46980B1 (fr) Compositions comprenant des souches bactériennes
MA45476B1 (fr) Compositions comprenant des souches bactériennes